PULMONARY HAEMORRHAGIE IN NEWBORN AND WAYS OF PREVENTION
DOI:
https://doi.org/10.46793/PP151008003VKeywords:
pulmonary hemorrhage, newborn, risk factors, preventionAbstract
Pulmonary hemorrhage is an acute deterioration that has a high rate of neonatal mortality and morbidity. Several risk factors that lead to pulmonary hemorrhage have been identified but the exact pathogenesis is not known. Important role in the development of pulmonary hemorrhage in neonatology is the development of pulmonary edema, which usually occurs due to increased pulmonary flow. Hemodynamically significant ductus arteriosus, prematurity, intrauterine growth and application of pulmonary surfactant significantly contribute to the increased incidence of pulmonary hemorrhage. There is no specific therapy. In this article, special attention was dedicated to the identification of risk factors and pulmonary hemorrhage treatments as a ways for its prevention
References
Berger TM, Allred EN, Van Marter LJ. Antecedents of clinically significant pulmonary hemorrhage among newborn infants. J Perinatology. 2000;20(5):295-300
Cole VA, Normand IC, Reynolds EO, Rivers RP. Pathogenesis of hemorrhagic pulmonary edema and massive pulmonary hemorrhage in the newborn. Paediatrics. 1973;
Evans N, Kluckow M. High pulmonary blood flow and pulmonary hemorrhage. Pediatr Res 1999; 45: 195a.
Greenough A, Milner AD. Pulmonary haemorrhage. In: Rennie JM, ed. Roberton’s textbook of neonatology, 4th edn. Edinburgh: Churchill Livingstone, 2005, p. 512–5.
Clyman RI, Chan CY, Mauray F, Chen YQ, Cox W, Seidner SR, Lord EM, Weiss H, Waleh N, Evans SM, Koch CJ. Permanent anatomic closure of the ductus arteriosus in newborn baboons: the roles of postnatal constriction, hypoxia, and gestation. Pediatr Res. 1999 Jan; 45(1):19-29.
Nick Evans. Patent ductus arteriosus in the neonate. Current Paediatrics (2005) 15, 381-389.
Evans N, Iyer P. Incompetance of the foramen ovale in preterm infant requring ventilation. J Pediatr 1994; 125:786-92.
Evans N, Iyer P. Assesment of ductus aretriousus shunting in preterm infants requiring ventilation: effect of iner-atrial shunting. J Pediatr 1994; 125:778-785.
Evans N., Kluckow M. Ductal shunting, high pulmonary blood floow, and pulmonary hemorrhage. J Pediatr 2000; 137:68-72.
Raju TN, Langenberg P. Pulmonary hemorrhage and exogenous surfactant therapy: a meta-analysis. J Pedatr 1993; 123:603-610.
Kaapa P, Seppanen M, Kero P, Saraste M. Pulmonary hemodynamics after synthetic surfactant replacment in neonatal respiratory distress syndrome. J Pediatr 1993; 123:115-9.
AlKharfy ТМ. High-Frequency Ventilation in the Management of Very-Low-Birth-Weight Infants with Pulmonary Hemorrhage AmJPerinatol. 2004; 21(1):19-26
Pandit PB, Dunn MS, Colucci EA. Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage. Paediatrics. 1995;95(1):32-36.
Olomu N, Kulkarni R, Manco - Johnson M, Treatment of Severe Pulmonary Hemorrhage With Activated Recombinant Factor VII (rFVIIa) in Very Low Birth Weight Infant. J perinatology. 2002;22(8):672-674.
Cetin H, Yalaz M, Akisu M, Karapinar DY, Kvakli K, Kultursay N. The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant. Blood Coagul Fibrinolysis. 2006;17(3):213-216.
Prof Nick Evans. Practical Guideline to PDA Treatment at RPA Hospital. 2013;Tomaszewska M, Stork E, Minich NM, Friedman H, Berlin S, Hack. Pulmonary hemorrhage: clinical course and outcomes among very low-birth-weight infants. Arch Pediatr Adolesc Med. 1999; 153(7):715-721.
